Drug intelligence / Profile preview

Fu-xiong San

Development stage: Unknown
Lead developer: Liaoning University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Topical

Overview

Fu-xiong San is a Traditional Chinese Medicine (TCM) herbal powder formulation developed by the Liaoning University of Traditional Chinese Medicine for the external treatment of pediatric pneumonia. It is applied topically to the chest or back, typically as a paste or plaster, to facilitate the transdermal absorption of active herbal ingredients. In clinical practice, it is used as an adjunctive 'exterior' treatment in combination with 'interior' treatments (such as oral granules like wind-heat or phlegm-heat formulas) and standard Western medical care (antibiotics like azithromycin or erythromycin). The formulation is intended to resolve phlegm, relieve cough, and reduce pulmonary inflammation in children.

Other names: Fuxiong SanFuxiong powder

Beyond the preview

Go deeper on Fu-xiong San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fu-xiong San.

Explore the full profile